TSE:DHT.UN DRI Healthcare Trust (DHT.UN) Stock Price, News & Analysis C$12.04 +0.21 (+1.78%) As of 02/21/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividend About DRI Healthcare Trust Stock (TSE:DHT.UN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DRI Healthcare Trust alerts:Sign Up Key Stats Today's RangeC$11.65▼C$12.0450-Day RangeC$11.64▼C$12.5052-Week RangeC$10.39▼C$17.43Volume70,045 shsAverage Volume39,453 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield3.82%Price TargetC$17.94Consensus RatingModerate Buy Company OverviewDRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence in the United States; European Union; Japan, and Rest of the world.Read More… DRI Healthcare Trust Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks29th Percentile Overall ScoreDHT.UN MarketRank™: DRI Healthcare Trust scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingDRI Healthcare Trust has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageDRI Healthcare Trust has only been the subject of 2 research reports in the past 90 days.Read more about DRI Healthcare Trust's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of DRI Healthcare Trust is -240.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of DRI Healthcare Trust is -240.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDRI Healthcare Trust has a P/B Ratio of 1.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for DHT.UN. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldDRI Healthcare Trust pays a meaningful dividend of 3.26%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthDRI Healthcare Trust does not have a long track record of dividend growth.Read more about DRI Healthcare Trust's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for DHT.UN. News and Social Media1.1 / 5News SentimentN/A News SentimentDRI Healthcare Trust has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for DRI Healthcare Trust this week, compared to 0 articles on an average week.MarketBeat Follows1 people have added DRI Healthcare Trust to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DRI Healthcare Trust insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.14% of the stock of DRI Healthcare Trust is held by insiders.Percentage Held by Institutions48.42% of the stock of DRI Healthcare Trust is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DRI Healthcare Trust's insider trading history. Receive DHT.UN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DRI Healthcare Trust and its competitors with MarketBeat's FREE daily newsletter. Email Address DHT.UN Stock News HeadlinesDRI Healthcare Trust (TSE:DHT.UN) Receives C$17.94 Consensus PT from AnalystsFebruary 14, 2025 | americanbankingnews.comDRI Healthcare Trust to Discuss 2024 Financial Results in Upcoming Conference CallJanuary 29, 2025 | tipranks.comDo this Before Elon’s Reveal on March 17thElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.February 22, 2025 | Brownstone Research (Ad)RBC Capital Sticks to Their Buy Rating for DRI Healthcare (DHT.UN)November 9, 2024 | markets.businessinsider.comDRI Healthcare Trust Acquires Royalty in Pre-Approval Sebetralstat for Up to $179 MlnNovember 4, 2024 | marketwatch.comDRI Healthcare Trust goes ex dividend tomorrowSeptember 26, 2024 | msn.comDRI HEALTHCARE TR (DHTRF)August 23, 2024 | uk.finance.yahoo.comClosing Bell: Dri Healthcare Trust up on Thursday (DHT-UN)July 19, 2024 | theglobeandmail.comSee More Headlines DHT.UN Stock Analysis - Frequently Asked Questions How have DHT.UN shares performed this year? DRI Healthcare Trust's stock was trading at C$11.83 at the start of the year. Since then, DHT.UN shares have increased by 1.8% and is now trading at C$12.04. View the best growth stocks for 2025 here. How do I buy shares of DRI Healthcare Trust? Shares of DHT.UN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:DHT.UN CUSIPN/A CIKN/A Webwww.dricapital.com Phone416-863-1865FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price TargetC$17.94 High Stock Price TargetC$22.00 Low Stock Price TargetC$14.00 Potential Upside/Downside+49.0%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.05) Trailing P/E RatioN/A Forward P/E Ratio18.95 P/E GrowthN/ANet IncomeC$9.73 million Net Margins5.02% Pretax MarginN/A Return on Equity2.06% Return on Assets4.22% Debt Debt-to-Equity Ratio63.20 Current Ratio1.36 Quick RatioN/A Sales & Book Value Annual SalesC$193.66 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueC$9.32 per share Price / Book1.29Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableN/A Beta0.60 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (TSE:DHT.UN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DRI Healthcare Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share DRI Healthcare Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.